- Home
- GTEC vs CLDI Comparison
GTEC vs CLDI Comparison
Compare GTEC & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTEC
- CLDI
- Stock Information
- Founded
- GTEC 2006
- CLDI 2014
- Country
- GTEC United States
- CLDI United States
- Employees
- GTEC N/A
- CLDI N/A
- Industry
- GTEC Industrial Machinery/Components
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GTEC Industrials
- CLDI Health Care
- Exchange
- GTEC Nasdaq
- CLDI Nasdaq
- Market Cap
- GTEC 21.2M
- CLDI 20.2M
- IPO Year
- GTEC N/A
- CLDI N/A
- Fundamental
- Price
- GTEC $1.39
- CLDI $1.76
- Analyst Decision
- GTEC
- CLDI
- Analyst Count
- GTEC 0
- CLDI 0
- Target Price
- GTEC N/A
- CLDI N/A
- AVG Volume (30 Days)
- GTEC 314.7K
- CLDI 1.1M
- Earning Date
- GTEC 08-13-2025
- CLDI 08-08-2025
- Dividend Yield
- GTEC N/A
- CLDI N/A
- EPS Growth
- GTEC N/A
- CLDI N/A
- EPS
- GTEC 0.53
- CLDI N/A
- Revenue
- GTEC $81,601,160.00
- CLDI N/A
- Revenue This Year
- GTEC $3.28
- CLDI N/A
- Revenue Next Year
- GTEC N/A
- CLDI N/A
- P/E Ratio
- GTEC $2.62
- CLDI N/A
- Revenue Growth
- GTEC N/A
- CLDI N/A
- 52 Week Low
- GTEC $1.14
- CLDI $1.61
- 52 Week High
- GTEC $2.94
- CLDI $46.68
- Technical
- Relative Strength Index (RSI)
- GTEC 39.68
- CLDI 29.56
- Support Level
- GTEC $1.14
- CLDI $1.61
- Resistance Level
- GTEC $1.33
- CLDI $6.06
- Average True Range (ATR)
- GTEC 0.13
- CLDI 0.77
- MACD
- GTEC -0.00
- CLDI -0.55
- Stochastic Oscillator
- GTEC 47.17
- CLDI 2.57
About GTEC Greenland Technologies Holding Corporation
Greenland Technologies Holding Corp is a developer of quality solutions in the material handling industry. It is a transmission and drivetrain systems provider for material handling equipment such as forklift trucks for industrial and logistic applications. Geographically, the company has its presence in Domestic and International markets and earns majority of the revenue from Domestic Sales.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.